Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Communication
  • Published:

Oral glutamine in paediatric oncology patients: a dose finding study

Abstract

Objective: The purpose of this study was to determine the most appropriate dose of oral glutamine to use in a further clinical study in paediatric oncology patients.

Design: This was a phase I, pharmokinetic study.

Setting: The study was carried out at The Yorkshire Regional Centre for Paediatric Oncology and Haematology, St James's University Hospital, Leeds, UK.

Subjects: Thirteen patients undergoing treatment for paediatric malignancy participated in this study. All 13 completed the study.

Interventions: The most appropriate dose was determined by patient acceptability and by plasma glutamine and ammonia levels measured at timed intervals after ingestion of a single glutamine dose.

Results: Doses of 0.35, 0.5 and 0.65 g/kg were well tolerated with no untoward plasma glutamine and ammonia levels. One patient was recruited to a higher dose of 0.75 g/kg, but the plasma glutamine and ammonia levels peaked at 2601 and 155 µmol/l, respectively. The ammonia level was greater than the acceptable upper limit. It was difficult to disperse the glutamine adequately at this dose, resulting in the suspension being found to be unpalatable and therefore no further patients were recruited at this dose.

Conclusion: It was concluded that 0.65 g/kg is a safe dose of glutamine to use in a clinical study in paediatric oncology patients.

Sponsorship: Scientific Hospital Supplies UK Ltd provided the L-glutamine and financial help for the biochemical analysis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Anderson, PM, Schroeder, G & Skubitz, KM (1998). Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer, 83, 1433–1439.

    Article  CAS  Google Scholar 

  • Bode, BP & Souba, WW (1999). Glutamine transport and human hepatocellular transformation. J. Parent Enteral Nutr., 23, S33–S37.

    Article  CAS  Google Scholar 

  • Buchman, AL (1996). Glutamine: is it a conditionally required nutrient for the Human gastrointestinal system?. J. Am. Coll. Nutr., 15, 199–205.

    Article  CAS  Google Scholar 

  • Buchman, AL, Moukarzel, AA, Bhuta, S, Belle, M, Ament, ME, Eckhert, CD, Hollander, D, Gornbein, J, Kopple, JD & Vijayaroghavan, SR (1995). Parenteral nutrition is associated with intestinal morphologic and functional changes in humans. J. Parent Enteral Nutr., 19, 453–460.

    Article  CAS  Google Scholar 

  • Burke, D, Alverdy, JC, Aays, E & Moss, GS (1989). Glutamine supplemented T.P.N. improves gut immune function. Arch. Surg., 124, 1396–1399.

    Article  CAS  Google Scholar 

  • Fox, AD, Kripke, SA, Berman, JR, Gregg Settle, R & Rombeau, JL (1987). Reduction of the severity of enterocolitis by glutamine supplemented enteral diets. Surg. Forum., 38, 43–44.

    Google Scholar 

  • Fox, AD, De Paula, JA, Kripke, SA, Palacio, CJ, Berman, JM, Gregg Settle, R & Rombeau, JL (1988). Glutamine supplemented elemental diets reduce endotoxaemia in a lethal model of enterocolitis. Surg. Forum, 39, 46–48.

    CAS  Google Scholar 

  • Fox, AD, Kripke, SA, DePaula, J, Berman, JM, Gregg Settle, R & Rombeau, JL (1989). Effect of glutamine supplemented enteral diet on methotrexate Induced enterocolitis. J. Parent Enteral Nutr., 12, 325–331.

    Article  Google Scholar 

  • Gardiner, KR, Kirk, SJ & Rowlands, BJ (1995). Novel substrates to maintain gut Integrity. Nutr. Res. Rev., 8, 43–64.

    Article  CAS  Google Scholar 

  • Green, A (1988). When and how should we measure plasma ammonia. Ann. Clin. Biochem., 25, 199–209.

    Article  CAS  Google Scholar 

  • Guedon, C, Schmitz, J, Lerebours, E, Metayer, J, Audran, E, Hemet, J & Colin, R (1986). Decreased brush border hydrolase activities without gross morphologic changes in human intestinal mucosa after prolonged total parenteral nutrition of adults. Gastroenterology, 90, 373–378.

    Article  CAS  Google Scholar 

  • Hall, JC, Heel, K & McCauley, R (1996). Glutamine. Br. J. Surg, 83, 305–312.

    Article  CAS  Google Scholar 

  • Jacobs, DO, Evans, DA, O'Dwyer, ST, Smith, RJ & Wilmore, DW (1987). Disparate effects of 5-Fluorouracil on the ileum and colon of enterally fed rats with protection by dietary glutamine. Surg. Forum, 38, 45–46.

    Google Scholar 

  • Jebb, SA, Marcus, R & Elia, M (1995). A pilot study of oral glutamine supplementation in patients receiving bone marrow transplant. Clin. Nutr., 14, 162–165.

    Article  CAS  Google Scholar 

  • Lacey, JM & Wilmore, DW (1990). Is glutamine a conditionally essential amino acid?. Nutr. Rev., 48, 297–309.

    Article  CAS  Google Scholar 

  • Lind, MJ (1995). Cytotoxic chemotherapy. Medicine, 422–426.

  • Meijer, AJ, Lamers, WH & Chamuleau, RAFM (1990). Nitrogen metabolism and ornithine cycle functions. Physiol. Rev., 70, 701–749.

    Article  CAS  Google Scholar 

  • Miller, AL (1999). Therapeutic considerations of L-Glutamine: a review of literature. Alter. Med. Rev., 4, 239–248.

    CAS  Google Scholar 

  • Rhoads, M (1999). Glutamine signaling in intestinal cells. J. Parent Enteral Nutr., 23, (Suppl) S38–S40.

    Article  CAS  Google Scholar 

  • Schloerb, PR & Skikne, BS (1999). Oral and parenteral glutamine in bone marrow Transplantation: a randomised, double blind study. J. Parent Enteral Nutr., 23, 117–122.

    Article  CAS  Google Scholar 

  • Skubitz, KM & Anderson, PM (1996). Oral glutamine to prevent chemotherapy induced stomatitis; a pilot study. J. Lab. Clin. Med., 127, 223–228.

    Article  CAS  Google Scholar 

  • Smith, RJ (1997). Glutamine supplemented nutrition. J. Parent Enteral Nutr., 21, 183–184.

    Article  CAS  Google Scholar 

  • Sweetenham, JW, Macbeth, FR, Mead, GM, Williams, JH & Whitehouse, J (1989). Clinical Oncology, 2nd edn Oxford: Blackwell Scientific

    Google Scholar 

  • Tremel, H, Kienle, B, Weilemann, LS, Stehle, P & Furst, P (1994). Glutamine dipeptide supplemented parenteral nutrition maintains intestinal function in the critically ill. Gastroenterology, 107, 1595–1601.

    Article  CAS  Google Scholar 

  • van Acker, BAC, von Meyenfeldt, MF, van der Hulst, RRWJ, Hulsewe, KWE, Wagenmakers, AJM, Deutz, NEP, de Blaauw, I, Dejong, CHC, van Kreel, BK & Soeters, PB (1999). Glutamine: the pivot of our nitrogen economy?. J. Parent Enteral Nutr., 23, S45–S48.

    Article  CAS  Google Scholar 

  • van der Hulst, RRW, van Kreel, BK, von Meyenfeldt, MF, Brummer, R-JM, Arends, J-W, Deutz, NEP & Soeters, PB (1993). Glutamine and the preservation of gut integrity. Lancet, 341, 1363–1365.

    Article  CAS  Google Scholar 

  • van Zaanen, HCT, van der Lelie, H, Trimmer, JG, Frust, P & Sauerwein, HP (1994). Parenteral glutamine dipepdite supplementation does not ameliorate chemotherapy induced toxicity. Cancer, 74, 2879–2884.

    Article  CAS  Google Scholar 

  • Wang, X-D, Jacobs, DO, O'Dwyer, ST, Smith, RJ & Wilmore, DW (1988). Glutamine enriched parenteral nutrition prevents mucosal atrophy following massive small bowel resection. Surg. Forum, 39, 44–46.

    CAS  Google Scholar 

  • Ziegler, TR, Benfell, K, Smith, RJ, Young, LS, Brown, E, Ferrari-Baliviera, E, Lowe, DK & Wilmore, DW (1990). Safety and metabolic effects of L-glutamine administration in humans. J. Parent Enteral Nutr., 14, 137S–146S.

    Article  CAS  Google Scholar 

  • Ziegler, TR, Young, LS, Benfell, K, Scheltinga, M, Hortos, K, Bye, R, Morrow, F, Jacobs, DO, Smith, RJ, Antin, JH & Wilmore, DW (1992). Clinical and metabolic efficacy of glutamine supplemented parenteral nutrition after bone marrow transplantation. Ann. Int. Med., 116, 821–828.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to SHS International for providing the L-glutamine and financial help for the biochemical analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E Ward.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ward, E., Picton, S., Reid, U. et al. Oral glutamine in paediatric oncology patients: a dose finding study. Eur J Clin Nutr 57, 31–36 (2003). https://doi.org/10.1038/sj.ejcn.1601517

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1601517

Keywords

This article is cited by

Search

Quick links